A methamphetamine rehabilitation trial reported exercise-related differences in selected circulating biomarkers, but not all markers changed differently between groups. Those blood measurements did not directly demonstrate repair of the blood–brain barrier.
Zhu and colleagues randomized methamphetamine-dependent men to 12 weeks of moderate aerobic exercise or conventional detoxification. The study measured neurofilament light chain in plasma and neuron-specific enolase and S100b in serum. These are biological markers associated with neurological processes, not measurements of methamphetamine itself. Matrix and analyte names are therefore essential to an accurate account.
The investigators reported significant between-group differences in changes in plasma neurofilament light chain and serum neuron-specific enolase. The corresponding serum S100b change was nonsignificant. A summary claiming that exercise improved all three markers would be inaccurate. The findings concern changes over an intervention period and should not be confused with an isolated post-treatment concentration or a validated clinical threshold.
Blood biomarkers provide indirect evidence. Without direct permeability measurement, tissue examination or an independently validated surrogate relationship, marker changes do not establish the extent of barrier repair or neural recovery in a particular person. The all-male rehabilitation population, limited intervention period and multiple outcomes further constrain inference. Functional improvement also requires functional evidence; a biomarker result cannot stand in for a cognitive or driving test. The study supports further investigation of exercise-related biological change, while the null S100b finding and differing sample matrices prevent a single broad ‘brain repair’ conclusion.
See why the specimen and measured substance matter for a different study and outcome.